328 related articles for article (PubMed ID: 3920319)
1. Monoclonal antibodies directed against gonococcal protein I vary in bactericidal activity.
Joiner KA; Warren KA; Tam M; Frank MM
J Immunol; 1985 May; 134(5):3411-9. PubMed ID: 3920319
[TBL] [Abstract][Full Text] [Related]
2. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
[TBL] [Abstract][Full Text] [Related]
3. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
[TBL] [Abstract][Full Text] [Related]
4. Bactericidal but not nonbactericidal C5b-9 is associated with distinctive outer membrane proteins in Neisseria gonorrhoeae.
Joiner KA; Warren KA; Hammer C; Frank MM
J Immunol; 1985 Mar; 134(3):1920-5. PubMed ID: 3918112
[TBL] [Abstract][Full Text] [Related]
5. Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex.
Kochi SK; Johnson RC; Dalmasso AP
J Immunol; 1991 Jun; 146(11):3964-70. PubMed ID: 2033266
[TBL] [Abstract][Full Text] [Related]
6. Role of TraT protein, an anticomplementary protein produced in Escherichia coli by R100 factor, in serum resistance.
Pramoonjago P; Kaneko M; Kinoshita T; Ohtsubo E; Takeda J; Hong KS; Inagi R; Inoue K
J Immunol; 1992 Feb; 148(3):827-36. PubMed ID: 1730875
[TBL] [Abstract][Full Text] [Related]
7. Complement binding on serum-sensitive and serum-resistant transformants of Neisseria gonorrhoeae: effect of presensitization with a non-bactericidal monoclonal antibody.
Joiner KA; Puentes SM; Warren KA; Scales RA; Judd RC
Microb Pathog; 1989 May; 6(5):343-50. PubMed ID: 2505012
[TBL] [Abstract][Full Text] [Related]
8. Interaction of Neisseria gonorrhoeae with classical complement components, C1-inhibitor, and a monoclonal antibody directed against the Neisserial H.8 antigen.
Schweinle JE; Hitchcock PJ; Tenner AJ; Hammer CH; Frank MM; Joiner KA
J Clin Invest; 1989 Feb; 83(2):397-403. PubMed ID: 2492308
[TBL] [Abstract][Full Text] [Related]
9. Assembly of the membrane attack complex promotes decay of the alternative pathway C3 convertase on Neisseria gonorrhoeae.
Densen P; McRill CM; Ross SC
J Immunol; 1988 Dec; 141(11):3902-9. PubMed ID: 3141507
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of action of blocking immunoglobulin G for Neisseria gonorrhoeae.
Joiner KA; Scales R; Warren KA; Frank MM; Rice PA
J Clin Invest; 1985 Nov; 76(5):1765-72. PubMed ID: 3932472
[TBL] [Abstract][Full Text] [Related]
11. A quantitative analysis of C3 binding to O-antigen capsule, lipopolysaccharide, and outer membrane protein of E. coli 0111B4.
Joiner KA; Goldman R; Schmetz M; Berger M; Hammer CH; Frank MM; Leive L
J Immunol; 1984 Jan; 132(1):369-75. PubMed ID: 6197449
[TBL] [Abstract][Full Text] [Related]
12. Idiotype and anti-anti-idiotype antibodies to Neisseria gonorrhoeae lipooligosaccharides with bactericidal activity but no cross-reactivity with red blood cell antigens.
Brossay L; Paradis G; Pépin A; Mourad W; Coté L; Hébert J
J Immunol; 1993 Jul; 151(1):234-43. PubMed ID: 7686935
[TBL] [Abstract][Full Text] [Related]
13. Toxoplasma gondii: mechanism of resistance to complement-mediated killing.
Fuhrman SA; Joiner KA
J Immunol; 1989 Feb; 142(3):940-7. PubMed ID: 2643665
[TBL] [Abstract][Full Text] [Related]
14. Multimeric C9 within C5b-9 deposits in unique locations in the cell wall of Salmonella typhimurium.
Joiner KA; Tartanian AB; Hammer CH; Schweinle JE
J Immunol; 1989 Jun; 142(12):4450-7. PubMed ID: 2656866
[TBL] [Abstract][Full Text] [Related]
15. Studies on the mechanism of bacterial resistance to complement-mediated killing. III. C5b-9 deposits stably on rough and type 7 S. pneumoniae without causing bacterial killing.
Joiner K; Brown E; Hammer C; Warren K; Frank M
J Immunol; 1983 Feb; 130(2):845-9. PubMed ID: 6848598
[TBL] [Abstract][Full Text] [Related]
16. Several epitopes on native human complement C9 are involved in interaction with the C5b-8 complex and other C9 molecules.
Kontermann R; Deppisch R; Rauterberg EW
Eur J Immunol; 1990 Mar; 20(3):623-8. PubMed ID: 1690659
[TBL] [Abstract][Full Text] [Related]
17. Antibody-mediated complement activation on nucleated cells. A quantitative analysis of the individual reaction steps.
Ollert MW; Kadlec JV; David K; Petrella EC; Bredehorst R; Vogel CW
J Immunol; 1994 Sep; 153(5):2213-21. PubMed ID: 8051421
[TBL] [Abstract][Full Text] [Related]
18. Studies on the mechanism of bacterial resistance to complement-mediated killing. I. Terminal complement components are deposited and released from Salmonella minnesota S218 without causing bacterial death.
Joiner KA; Hammer CH; Brown EJ; Cole RJ; Frank MM
J Exp Med; 1982 Mar; 155(3):797-808. PubMed ID: 6801179
[TBL] [Abstract][Full Text] [Related]
19. Nonbactericidal antibodies against Neisseria gonorrhoeae: evaluation of their blocking effect on bactericidal antibodies directed against outer membrane antigens.
Virji M; Heckels JE
J Gen Microbiol; 1988 Oct; 134(10):2703-11. PubMed ID: 2474627
[TBL] [Abstract][Full Text] [Related]
20. Complement resistance in Borrelia burgdorferi strain 297: outer membrane proteins prevent MAC formation at lysis susceptible sites.
Patarakul K; Cole MF; Hughes CA
Microb Pathog; 1999 Jul; 27(1):25-41. PubMed ID: 10371707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]